Phillips-Medisize Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Phillips-Medisize Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7277
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phillips-Medisize Corp (Phillips-Medisize) is a provider of outsourced design and manufacturing services to medical, defense, consumer, and automotive markets. The company operates as a subsidiary of Molex LLC. It offers a broad range of pre-production and production services. The company offers a range of drug delivery, medical device and diagnostic products, including glucose meters, disposable insulin pens, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components. Its major capabilities include design development, prototyping, plastic injection molding, metal injection molding (MIM), magnesium thixomolding, testing, secondary operations, multi-shot liquid silicone rubber, micro molding, sub and complete assembly. The company has manufacturing and design facilities in the US, Mexico, Finland, Switzerland, the Netherlands, Czech Republic, Ireland and China. Phillips-Medisize is headquartered in Hudson, Wisconsin, the US.

Phillips-Medisize Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Phillips-Medisize Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Phillips-Medisize Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Phillips-Medisize Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Phillips-Medisize Corp, Medical Equipment, Deal Details 12
Private Equity 12
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 12
Golden Gate Capital To Acquire Phillips-Medisize From Kohlberg 13
Partnerships 15
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 15
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 16
Phillips-Medisize Partners with InterSystems 17
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 18
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 19
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 20
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 21
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 22
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 23
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 24
Acquisition 25
Flexicare Medical Acquires Medisize 25
Molex Acquires Phillips-Medisize 26
Phillips-Medisize Acquires Medicom Innovation Partner 27
Phillips-Medisize To Acquire Omni Manufacturing Services From Adval Tech 28
Phillips-Medisize To Acquire Adval Tech Medical (Suzhou) From Adval Tech 29
Phillips-Medisize Corp – Key Competitors 30
Phillips-Medisize Corp – Key Employees 31
Phillips-Medisize Corp – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 32
Recent Developments 33
Strategy And Business Planning 33
Oct 08, 2018: Phillips-Medisize partners with InterSystems in connected health platform 33
Aug 23, 2018: Phillips-medisize continues to attract industry thought leaders to connected health team 34
May 17, 2018: Phillips-Medisize Opens New Facility in China 35
May 01, 2018: Phillips-Medisize Expands and Adds Drug Handling Capability at New Richmond Facility 36
Jan 18, 2018: Phillips-Medisize Announces Expansion of Significant Medical Customer for Molex Little Rock Facility 37
Dec 06, 2017: Phillips-Medisize Creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices 38
Corporate Communications 39
May 17, 2018: Phillips-Medisize Opens New Facility in China 39
May 18, 2017: Phillips-Medisize Appoints Michael Ratigan 40
Feb 07, 2017: Phillips-Medisize Adds Dr. Robert Langer to Strategic Advisory Board 41
Product News 42
May 15, 2018: Phillips-Medisize Invites Visitors to Discuss Drug Delivery Partnerships at Innopack Pharma Confex India 42
Apr 13, 2018: Phillips-Medisize Invites Visitors to Discuss Connected Health During Medtec Europe 43
Nov 28, 2017: Phillips-Medisize Exhibits During DDL2017 44
Nov 02, 2017: Phillips-Medisize Presents on Next Generation Connected Drug Delivery Devices During PDA Conference 45
Oct 19, 2017: Phillips-Medisize Showcases Connected Drug Delivery Devices at InnoPack 46
Feb 01, 2017: Phillips-Medisize and Medicom Innovation Partner to Present at Drug Delivery Partnerships 2017 47
Jan 24, 2017: Phillips-Medisize Focuses on Connected Drug Delivery Devices for Improved Therapeutic Outcomes during Pharmapack, Paris 48
Other Significant Developments 49
Sep 26, 2018: Enhanced Capabilities Enable Phillips-Medisize to Better Serve Customers 49
Jul 24, 2018: Phillips-Medisize enhances integrated connected health platform 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Phillips-Medisize Corp, Medical Equipment, Key Facts 2
Phillips-Medisize Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Phillips-Medisize Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Phillips-Medisize Corp, Deals By Market, 2012 to YTD 2018 9
Phillips-Medisize Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 12
Golden Gate Capital To Acquire Phillips-Medisize From Kohlberg 13
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 15
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 16
Phillips-Medisize Partners with InterSystems 17
Dance Biopharm Enters into Co-Development Agreement with Phillips-Medisize 18
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 19
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 20
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 21
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 22
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 23
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 24
Flexicare Medical Acquires Medisize 25
Molex Acquires Phillips-Medisize 26
Phillips-Medisize Acquires Medicom Innovation Partner 27
Phillips-Medisize To Acquire Omni Manufacturing Services From Adval Tech 28
Phillips-Medisize To Acquire Adval Tech Medical (Suzhou) From Adval Tech 29
Phillips-Medisize Corp, Key Competitors 30
Phillips-Medisize Corp, Key Employees 31
Phillips-Medisize Corp, Other Locations 32
Phillips-Medisize Corp, Subsidiaries 32
Phillips-Medisize Corp, Joint Venture 32

List of Figures
Phillips-Medisize Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Phillips-Medisize Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Phillips-Medisize Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Phillips-Medisize Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Phillips-Medisize Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Phillips-Medisize Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NV Energy Inc:企業の戦略的SWOT分析
    NV Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BJ’s Wholesale Club Inc:企業の戦略・SWOT・財務情報
    BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report Summary BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Arotech Corporation:企業の戦略・SWOT・財務情報
    Arotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Arotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein int …
  • RentPath, LLC:企業の戦略・SWOT・財務分析
    RentPath, LLC - Strategy, SWOT and Corporate Finance Report Summary RentPath, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • AVEVA Group Plc:企業の戦略・SWOT・財務情報
    AVEVA Group Plc - Strategy, SWOT and Corporate Finance Report Summary AVEVA Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TFS Financial Corp:企業の戦略・SWOT・財務分析
    TFS Financial Corp - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Culture Landmark Investment Ltd
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • PTT Public Company Limited:企業の戦略・SWOT・財務分析
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Flotek Industries Inc (FTK):企業の財務・戦略的SWOT分析
    Summary Flotek Industries Inc (Flotek) is a developer of chemistry based technology solutions for energy, industrial and consumer applications. The company offers stimulation chemistry, cementing chemistry, improved oil recovery chemistry, drilling fluid additives, and coil tubing chemistry. Its sti …
  • Chick-fil-A Inc:企業の戦略・SWOT・財務情報
    Chick-fil-A Inc - Strategy, SWOT and Corporate Finance Report Summary Chick-fil-A Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Syncardia Systems LLC:企業の戦略的SWOT分析
    Syncardia Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • National Gypsum Co:企業の戦略・SWOT・財務情報
    National Gypsum Co - Strategy, SWOT and Corporate Finance Report Summary National Gypsum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Energir LP:企業の戦略的SWOT分析
    Energir LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • North China Pharmaceutical Group Corp-製薬・医療分野:企業M&A・提携分析
    Summary North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes antibiotic bulks and formulations, vitamins and nutrition products. The company’s products comprise antibiotics, penicillin, amoxicillin, streptomycin sulfate, cefradine, 7-ADCA, …
  • The Lion Group:企業の戦略・SWOT・財務情報
    The Lion Group - Strategy, SWOT and Corporate Finance Report Summary The Lion Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Grupo Famsa, S.A.B. de C.V.:戦略・SWOT・企業財務分析
    Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mahindra & Mahindra Limited:戦略・SWOT・企業財務分析
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆